New Administration Option Now Available With RespiSure-ONE®
Two-dose protocol gives veterinarians and producers flexibility for helping protect piglets
FLORHAM PARK, N.J., Jan. 29, 2014 — Zoetis is giving swine veterinarians and pork producers another on-label vaccination option by making RespiSure-ONE® available for a two-dose protocol.
With the new label indication, RespiSure-ONE can be administered intramuscularly with a 1 mL injection at processing and a second 1 mL injection at weaning. This vaccination option is in addition to the previously approved one-dose 2 mL injection at processing.
“Providing this flexible dose option demonstrates our commitment to giving veterinarians and producers solutions that fit their needs and help protect pig health,” said Richard Swalla, DVM, Pork Technical Services, Zoetis.
RespiSure-ONE is licensed for the vaccination of healthy swine 1 day of age or older as an aid in reducing chronic pneumonia caused by Mycoplasma hyopneumoniae (M. hyo). M. hyo is a common bacterial pathogen that infects up to 80% of swine around the world.1,2 It can reduce average daily gain and decrease feed efficiency. The bacteria typically transfers from sow to piglet during lactation as well as from older to younger pigs.
With the new administration option, piglets still get vaccinated on day one, which is important because they may be infected with M. hyo during the first three weeks of life.3,4
“You can be confident that your pigs are getting the protection they need against M. hyo whether you decide to administer two doses or one dose of RespiSure-ONE,” Dr. Swalla said.
For more information on RespiSure-ONE and the protocol options, visit www.earlypigvac.com or contact your local Zoetis representative.
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2012, the company generated annual revenues of $4.3 billion. With approximately 9,300 employees worldwide at the beginning of 2013, Zoetis has a local presence in approximately 70 countries, including 29 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information on the company, visit www.zoetisUS.com.
Zoetis is the proud sponsor with the Smithsonian Institution Traveling Exhibition Service and the American Veterinary Medical Association of the mobile educational exhibit Animal Connections: Our Journey Together. Families visiting the exhibit will explore the vast bonds between people and animals and learn about the important role veterinarians play in protecting animal and human health.
For further information, Contact:
1 Ross RF. Mycoplasmal diseases. In: Straw BE, D’Allaire S, Mengling WL, et al., eds. Diseases of Swine. 8th ed. Iowa State University Press, 1999;495-509.
2 Done S. Enzootic pneumonia (mycoplasmosis) revisited. J Pig Vet Soc 1996;38:40-61.
3 Fano E, Pijoan C, Dee S, Deen J. Effect of Mycoplasma hyopneumoniae colonization at weaning on disease severity in growing pigs. Can J Vet Res 2007;71(3):195-200.
4 Sibila M, Nofrarias M, Lopez-Soria S, Segales J, Riera P, Llopart D, Calsamiglia M. Exploratory field study on Mycoplasma hyopneumoniae infection in suckling pigs. Vet Microbiol 2007;121(3,4):352-356.
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States